Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Patent CN115960142A discloses a one-pot synthesis of osmium heterocycles enabling high-yield hydrosilylation under air, offering cost-effective solutions for fine chemical manufacturing.
Novel chiral spiro ammonium salt catalyst patent CN115197145B enables high-yield oxy-Cope rearrangement. Delivers superior enantioselectivity and scalable manufacturing for pharmaceutical intermediates.
Novel chiral phosphoric acid catalyzed synthesis of axially chiral indole-naphthalene compounds with high enantioselectivity for pharmaceutical applications.
Patent CN107629049A offers efficient pyrido isoindole synthesis. Low cost catalysts, air conditions, high yield for pharma intermediates.
Novel Rose Bengal catalyzed method for alpha-indole glycine derivatives offers green, scalable production for pharmaceutical intermediates.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production with reduced costs and scalable supply chain reliability for global pharma.
Novel synthesis method offers high enantioselectivity and cost reduction for asymmetric MBH and cyclization reactions in pharmaceutical manufacturing.
Patent CN108864110B reveals a novel organocatalytic route for anticancer naphthoquinopyrans, offering improved safety and scalability for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalysis enables efficient indolocyclopentanes synthesis. Offers high selectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel Pd-catalyzed carbonylation method for 2-trifluoromethyl imidazoles. High efficiency, mild conditions, scalable process for API intermediates.
Novel cobalt-catalyzed method reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN112920173A details a mild chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing potential.
Novel bulky chiral quaternary ammonium salt enhances enantioselectivity in olefin oxidation, offering cost-effective solutions for API manufacturing.
Novel synthesis route for chiral indolo oxa rings offers high yield and enantioselectivity. Ideal for pharmaceutical intermediates manufacturing with reduced costs and scalable production capabilities.
Patent CN108558692B reveals a mild NHC-catalyzed amidation route offering high yields and simplified purification for cost-effective pharmaceutical intermediate manufacturing.
Patent CN111892545A reveals a green photocatalytic route for quinoxalinones. Achieve high yields without transition metals, ensuring cost reduction in API manufacturing and reliable supply.
Patent CN113087689B reveals a green iodine-catalyzed route for high-purity 5-amino-gamma-lactone derivatives, offering substantial cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.